Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS Genet ; 17(9): e1009787, 2021 09.
Article in English | MEDLINE | ID: mdl-34478447

ABSTRACT

Comparative genomics has enabled the identification of genes that potentially evolved de novo from non-coding sequences. Many such genes are expressed in male reproductive tissues, but their functions remain poorly understood. To address this, we conducted a functional genetic screen of over 40 putative de novo genes with testis-enriched expression in Drosophila melanogaster and identified one gene, atlas, required for male fertility. Detailed genetic and cytological analyses showed that atlas is required for proper chromatin condensation during the final stages of spermatogenesis. Atlas protein is expressed in spermatid nuclei and facilitates the transition from histone- to protamine-based chromatin packaging. Complementary evolutionary analyses revealed the complex evolutionary history of atlas. The protein-coding portion of the gene likely arose at the base of the Drosophila genus on the X chromosome but was unlikely to be essential, as it was then lost in several independent lineages. Within the last ~15 million years, however, the gene moved to an autosome, where it fused with a conserved non-coding RNA and evolved a non-redundant role in male fertility. Altogether, this study provides insight into the integration of novel genes into biological processes, the links between genomic innovation and functional evolution, and the genetic control of a fundamental developmental process, gametogenesis.


Subject(s)
Chromatin/metabolism , Drosophila melanogaster/genetics , Evolution, Molecular , Spermatids/metabolism , Animals , Cell Nucleus/metabolism , Clustered Regularly Interspaced Short Palindromic Repeats , Fertility/genetics , Male , RNA Interference , Spermatogenesis/genetics
2.
Prim Care ; 37(2): 407-21, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20493343

ABSTRACT

Chronic pain can be a frustrating condition for patient and clinician. The integrative medicine approach to pain can offer hope, adding safe complementary and alternative medical (CAM) therapies to mitigate pain and suffering. Such CAM therapies include nutrition, supplements and herbs, manual medicine, acupuncture, yoga, and mind-body approaches. The evidence is heterogeneous regarding these approaches, but some evidence suggests efficacy and confirms safety. The integrative medicine approach can be beneficial in a patient with chronic pain.


Subject(s)
Integrative Medicine , Pain Management , Chronic Disease , Dietary Supplements , Feeding Behavior , Humans , Phytotherapy , Plant Preparations
3.
Am Fam Physician ; 81(4): 465-8, 2010 Feb 15.
Article in English | MEDLINE | ID: mdl-20148500

ABSTRACT

Hawthorn medicinal extract has long been a favored herbal remedy in Europe. The active components of this slow-acting cardiotonic agent are thought to be flavonoids and oligomeric procyanidins. The most studied hawthorn extracts are WS 1442 and LI 132. Reviews of placebo- controlled trials have reported both subjective and objective improvement in patients with mild forms of heart failure (New York Heart Association classes I through III). Other studies of hawthorn in patients with heart failure have revealed improvement in clinical symptoms, pressure-heart rate product, left ventricular ejection fraction, and patients' subjective sense of well-being. However, there is no evidence of a notable reduction in mortality or sudden death. Hawthorn is well tolerated; the most common adverse effects are vertigo and dizziness. Theoretic interactions exist with antiarrhythmics, antihypertensives, digoxin, and antihyperlipidemic agents. Proven conventional therapies for heart failure are still recommended until the safety and effectiveness of hawthorn has been proven in long-term studies.


Subject(s)
Crataegus/chemistry , Heart Failure/drug therapy , Plant Extracts/therapeutic use , Cardiotonic Agents/adverse effects , Cardiotonic Agents/pharmacology , Cardiotonic Agents/therapeutic use , Flavonoids/adverse effects , Flavonoids/therapeutic use , Humans , Plant Extracts/adverse effects , Plant Extracts/chemistry
4.
Ann Pharmacother ; 39(12): 2128-30, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16288069

ABSTRACT

OBJECTIVE: To report a case of Jarisch-Herxheimer reaction (JHR) in a patient with presumed neurosyphilis and HIV. CASE SUMMARY: A 45-year-old HIV-positive man (CD4+ count 450 cells/mm(3) and history of AIDS-defining illness) presented with JHR after an initial intravenous dose of penicillin G for presumed neurosyphilis. The patient described feeling cold with worsening headache and chills approximately one hour after infusion of the first dose of penicillin. On examination, rigors, shallow inspirations, and chills were noted. He was afebrile, tachycardic, and tachypneic and had an oxygen saturation of 94% while breathing room air. His symptoms resolved within 10 minutes. Initially, this reaction was thought to be a result of a drug allergy, but upon further review, we determined that it was JHR. DISCUSSION: It is not uncommon to confuse drug allergy with JHR. An objective causality assessment suggests that the JHR in our patient was probably related to penicillin. JHR is a self-limiting condition that warrants the continuation of antibiotic treatment in syphilis patients. CONCLUSIONS: JHR should be an anticipated reaction to early doses of antibiotic treatment for treponemal diseases, such as syphilis. Treatment of JHR is largely supportive, such as administering antipyretic and antiinflammatory agents. Antibiotic treatment should be continued.


Subject(s)
Neurosyphilis/complications , Penicillin G/adverse effects , Penicillins/adverse effects , HIV Infections/complications , HIV Seropositivity , Humans , Male , Middle Aged , Neurosyphilis/drug therapy , Penicillin G/therapeutic use , Penicillins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...